Department of Clinical Pharmacology, New MS Building, First Floor and Second Floor (ward 24)
About the Department
Department of Clinical Pharmacology was established in June 1995 as a super-specialty Department
Milestones
CDRI Clinical Pharmacology Unit
ICMR- Advanced Centre in Clinical Pharmacology [2000]
DBT- Clinical Research Training Centre [2005]
Regional Centre for the PvPI [2010]
ICMR-Advanced centre in Clinical Pharmacology –PK PD Anti-infectives [2018]
ICMR-Advanced centre for Product development [2019]
Allergy OPD for testing patients referred with suspected drug allergies [2020]
Achievements
Addition of pharmacogenetics of azathioprine – services for TPMT
Addition of TDM of Voriconazole
Development of method for detection of hydroxyurea
Development of method for detection of mycophenolate mofetil
Selected as one of the phase 1 center of excellence by ICMR in 2023
Future outlook
To develop a method for TDM of amikacin
Development of method for detection of thalidomide
Events
Two Pharmacovigilance ‘Advanced Level Training’ Workshops were conducted as a Regional Training Centre under the aegis of Pharmacovigilance Program of India (PvPI)
Name
Dr Nithya Gogtay
Designation
Professor & HoD
Qualification
MBBS, MD, DNB, PhD
Email id
njgogtay@hotmail.com
Teaching experience
25 years
Name
Dr Mahesh N Belhekar
Designation
Associate Professor
Qualification
MBBS, MD
Email id
belhekardrmahesh4@gmail.com
Teaching experience
12 years
Name
Dr Bhaskar Krishnamurthy
Designation
Assistant Professor
Qualification
MBBS, MD, DM
Email id
drbhaskar.kemgsmc@gmail.com
Teaching experience
3 years
Facilities/services available in your department
Pharmacogenetics laboratory
Therapeutic Drug Monitoring (TDM) laboratory
Parasitology (Malaria) laboratory
Biochemistry laboratory
Phase 1 Unit
ADR monitoring center
Allergy OPD
Facility Photograph/video
Wards – Ward 24 Second floor, New MS Building, Dept of Clinical Pharmacology
Special OPD/Clinic – Allergy OPD
Types of OPDs with timings day wise
TDM OPD (diagnostic OPD) run every Friday and Saturday from 8:00 am to 12:30 pm
Pharmacogenetics OPD daily from 9:00 am to 12:30 pm
Allergy OPD – every Friday from 8:00 am to 12:30 pm
Patient Feedback – not applicable
Patient Education – patients are sensitized about consumer reporting of ADRs as per the Pharmacovigilance program of India (PvPI)
Courses offered – DM (Clinical Pharmacology), PhD (Clinical Pharmacology), PhD (Pharmaceutical Medicine), PhD (Applied Biology), MSc (Applied Biology), Fellowship in Drug Development
Teaching schedule / Student activities – PG seminars every Wednesday 12:00 pm to 1:00 pm, Journal clubs every Thursday 12:00 pm to 1:00 pm, common teaching program every Saturday 12:00 pm to 1:00 pm.
Workshop/CME – Canvas of Clinical Pharmacology Workshop (CCPW) every alternate year as a National Clinical Pharmacology conference
Awards
Dr Ananya Rakshit (First year DM resident) presented an oral paper on ‘Status of registration and re-registration of Ethics Committee in CDSCO and DHR – evaluation of extent of Ethical oversight in the country’ at the 1st Annual Conference of National Association of Pharmacology and Therapeutics (NAPTICON) at Mangalore, Karnataka (28th – 29th October 2022).
Dr Dhruve Soni (Final year DM resident) presented an oral paper on ‘Evaluation of the risk of allergy to COVID-19 vaccines in people with a history of allergic diatheses at the 1st Annual Conference of National Association of Pharmacology and Therapeutics (NAPTICON) at Mangalore, Karnataka (28th – 29th October 2022).
Dr Sukant Pandit (First year DM resident) presented an oral paper on ‘Comparison of WHO-UMC and Naranjo scales for causality assessment of reported adverse drug reactions’ at the 1st Annual Conference of National Association of Pharmacology and Therapeutics (NAPTICON) at Mangalore, Karnataka (28th – 29th October 2022).
Second prize for oral presentation: Dr Bhaskar Krishnamurthy (Assistant Professor) has won the 2nd prize in the oral presentation category for the paper ‘Economic analysis of renal transplant services in a tertiary care hospital’ at the 14th Annual Conference of the ‘Indian Society for Rational Pharmacotherapeutics’ (ISRPTcon) in Hyderabad from (10th – 12th of November 2022).
Dr Jeffrey Pradeep Raj (Assistant Professor) presented an oral paper on ‘Can a Discrete Choice Experiment (DCE) help understand COVID-19 vaccine Hesitancy? A study from India’ at the 22nd Annual FERCAP (Forum for Ethical Review Committees in the Asian and Western Pacific Region) Conference, 2022 at Daegu, South Korea (27th – 30th November 2022).
Dr Palvi Kudyar (Assistant Professor) presented an oral paper on ‘Evaluation of satisfaction and reasons for participation in a COVID-19 Vaccine Clinical Trial: a single Centre observational study’ at the 22nd Annual FERCAP (Forum for Ethical Review Committees in the Asian and Western Pacific Region) Conference, 2022 at Daegu, South Korea (27th – 30th November 2022).
Dr Dhruve Soni (Final year DM resident) presented an oral paper on ‘Assessment of factors that motivate participants to take part in a COVID-19 vaccine study’ at the 22nd Annual FERCAP (Forum for Ethical Review Committees in the Asian and Western Pacific Region) Conference, 2022 at Daegu, South Korea (27th – 30th November 2022).
Year
Number of Publications
2023
10
2022
12
2021
18
2020
17
2019
11
2018
18
2017
17
2016
17
2015
12
2014
16
2013
13
2012
08
Evaluation of population pharmacokinetics of levetiracetam in patients with epilepsy
Prediction of factors influencing Indian adults’ likelihood of accepting any Covid-19 vaccination and their willingness to pay – a Discrete Choice Experiment (DCE) study
A randomized, open label, parallel, proof of concept study to evaluate efficacy and safety of topical Phenytoin cream in adult patients with Diabetic ulcers
A Multi-Center, Prospective, Open-Label, Assessor-Blinded, Randomised, Controlled, Non-Inferiority, Pivotal Clinical Investigation to evaluate the Performance and Safety of 3-D Scaffold Matrix – A Class C Medical Device Bone Void Filler as a Bone Graft Substitute in Orthopaedic Surgery
A prospective, randomized, double blind, placebo-controlled study of ZYBK2 to evaluate the safety, tolerability, pharmacokinetics, and pharmacodynamics in patients with Rheumatoid arthritis
A multinational, open-label, randomised, controlled trial to investigate efficacy and safety of NNC0365-3769 (Mim8) in adults and adolescents with haemophilia A with or without inhibitors.
Safety, efficacy, and exposure of subcutaneously administered NNC0365 3769 (Mim8) prophylaxis in children with haemophilia A with or without FVIII Inhibitors
A Prospective, Nonrandomized, Open Label, Single Arm, Multicenter, Phase 3 Clinical Study to Evaluate the Efficacy and Safety of Human Normal Immunoglobulin for Intravenous Administration in Adult Patients with Chronic Primary Immune Thrombocytopenia
A Phase III Prospective, multicentric, clinical study in the management of pregnancy induced cholestasis to evaluate the efficacy and safety of Ursodeoxycholic acid (Udiliv) Tablets [PICTURE study]
Community Activities - During the National Pharmacovigilance week in the month of September 2022, on 23rd September 2022, the Pharmacovigilance team of our department have created awareness of Adverse Drug Reactions among patients in Geriatric OPD at Kamgar Kalyan Kendra, Naigaon community centre along with Community Medicine Department.
